Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for
Moderate Aortic Valve Stenosis
Location: Boston MA, Albany NY, The Bronx NY, Philadelphia PA,
Sponsor: Kardigan, Inc.
Sex: All
Age: 50+
Code: NCT07001800
Phase 2, Phase 3, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Boston MA, Canton OH, Wilson NC, Grand Rapids MI,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05714839
Phase 1, Phase 2, Recruiting
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
for
Stroke
Location: Boston MA, Baltimore MD, Durham NC, Cincinnati OH,
Sponsor: State University of New York at Buffalo
Sex: All
Age: 18+
Code: NCT00682695
Recruiting
The Impact of Music Medicine on Preterm Brain Development and Behavior
for
Infant Development, Language Development, Prematurity, Stress
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: Boston MA, New York NY, Fairfax VA, Pittsburgh PA,
Sponsor: TRIANA Biomedicines, Inc.
Sex: All
Age: 18+
Code: NCT07491497
Phase 1, Phase 2, Recruiting
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
for
Von Hippel-Lindau Disease, Malignant Neoplasms
Location: Boston MA, Philadelphia PA, Pittsburgh PA, Detroit MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07405164
Phase 3, Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
for
Bladder Cancer
Location: Boston MA, New York NY, Morristown NJ, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07419295
Phase 3, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: Providence RI, New Bedford MA, Lebanon NH, Yonkers NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase 3, Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for
Crohn's Disease, Obesity or Overweight
Location: Providence RI, New Bedford MA, Lebanon NH, Yonkers NY,
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
for
Systemic Lupus Erythematosus,
Location: Boston MA, Great Neck NY, New York NY, Rochester NY,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT06570798
Phase 2, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Worcester MA, Pittsburgh PA, Detroit MI, Edgewood KY,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06682988
Phase 2, Recruiting
Germline Testing for Predisposition to Myeloid Malignancies
for
Myeloid Malignancy, Genetic Predisposition to Disease,
Location: Boston MA
Sponsor: Christopher Reilly
Sex: All
Age: 18+
Code: NCT07112287
Recruiting
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Boston MA, Philadelphia PA, Arlington VA, Fairfield OH,
Sponsor: BicycleTx Limited
Sex: All
Age: 18+
Code: NCT06933329
Phase 2, Recruiting
A Global Study of the PETAL Consortium
for
T-Cell and NK-Cell Neoplasm
Location: Boston MA, Hackensack NJ, Philadelphia PA,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06067347
Recruiting
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma